Testing patients' lungs: Spirometry as part of the physical examination

Clinical Therapeutics

Volumn 21, Issue 11, 1999, Pages 1908-1922

  Petty, Thomas L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b HealthOne   (United States)

Author keywords

Family practice; Lung disease; Predictive value of tests; Risk factors; Smoking adverse effects; Spirometry

Indexed keywords

ASTHMA; CYSTIC FIBROSIS; HUMAN; LUNG EXAMINATION; LUNG FUNCTION; MEDICAL EXAMINATION; PATIENT MONITORING; REVIEW; SPIROMETRY;

EID: 0032763828     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)86739-9     Document Type: Note

References (29)

1. 1. Petty TL. The National Lung Health Education Program: A new frontier for respiratory care practitioners. Respir Care. 1998;43:183-184.
2. 2. National Lung Health Education Program. Patients who will benefit. Available at: http://www.nlhep.org/pbenefit.htm. Accessed August 2, 1999.
3. 1. The Lung Health Study. JAMA. 1994;272:1497-1505.
4. 4. Rodriguez BL, Masaki K, Burchfiel C, et al. Pulmonary function decline and 17-year total mortality: The Honolulu Heart Program. Am J Epidemiol. 1994;140:398-408.
5. 5. Strachan DP. Ventilatory function as a predictor of fatal stroke. Br Med J. 1991; 302:84-87.
6. 6. Hankinson JL. Office spirometry: Does poor quality render it impractical? Chest. 1999;116:276-277.
7. 7. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general United States population. Am J Respir Crit Care Med. 1999;159:179-187.
8. 8. Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: The importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116:416-423.
9. 9. Burrows B, Knudson RJ, Camilli AE, et al. The "horse racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 1987;135:788-793.
10. 10. Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure. The Framingham Study. Circulation. 1974;49:1160-1166.
11. 1 by age and smoking status: Facts, figures, and fallacies. Thorax. 1997;52:820-827.
12. 12. Ferguson GT, Enright PL, Buist S, et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. In press.
13. 13. Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med. 1985;14:655-662.
14. 14. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: The Mayo Program. J Occup Environ Med. 1986;28: 746-750.
15. 15. Fontana RS. Screening for lung cancer. In: Miller AB, ed. Screening for Cancer. New York, NY: Academic Press; 1985: 163-219.
16. 16. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering Study in New York. Chest. 1984;86:44-53.
17. 17. Tockman MS. Survival and mortality from lung cancer in a screened population. The Johns Hopkins Study. Chest. 1986;89 (Suppl 1):324-325.
18. 18. Eddy DM. Screening for lung cancer. Ann Intern Med. 1989;111:232-237.
19. 19. Petty TL. Time to rethink lung cancer screening. J Respir Dis. 1991;12:403-406.
20. 20. Petty TL. Lung cancer screening. Compr Ther. 1995;21:432-437.
21. 21. Cohen BH, Diamond EL, Graves CG, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. 1977;2:523-526.
22. 22. Cohen BH. Is pulmonary dysfunction the common denominator for the multiple effects of cigarette smoking? Lancet. 1978;2:1024-1027.
23. 23. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease: A prospective, matched, controlled study. Ann Intern Med. 1986;105:503-507.
24. 24. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106:512-518.
25. 25. Lange P, Nyboe J, Appleyard M, et al. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 1990; 141:613-617.
26. 26. Sorlie P, Lakatos E, Kannel WB, Celli B. Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: The Framingham Study. J Chron Dis. 1987;40:849-856.
27. 1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med. 1995;151: 390-398.
28. 28. Higgins MW, Keller JB, Becker M, et al. An index of risk for obstructive airways disease. Am Rev Respir Dis. 1982;125: 144-151.
29. 29. Badgett RG, Tanaka DJ, Hunt DK, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med. 1993;94:188-196.